Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these
children may require surgery. In this study, researchers affiliated with the University of
Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of
hyperinsulinism that may be cured by surgery. Eligible participants in this study will have
positron emission tomography (PET) scans with F-DOPA prior to surgery.